177 related articles for article (PubMed ID: 11070454)
1. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
Ferrari M; Balestreri F; Baratieri S; Biasin C; Oldani V; Lo Cascio V
Respiration; 2000; 67(5):510-3. PubMed ID: 11070454
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test.
Ferrari M; Segattini C; Zanon R; Bertaiola M; Balestreri F; Brotto E; Lo Cascio V
Respiration; 2002; 69(6):509-12. PubMed ID: 12457003
[TBL] [Abstract][Full Text] [Related]
3. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
[TBL] [Abstract][Full Text] [Related]
4. Formoterol provides long-lasting protection against exercise-induced bronchospasm.
Bronsky EA; Yegen U; Yeh CM; Larsen LV; Della Cioppa G
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):407-12. PubMed ID: 12392386
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G
Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546
[TBL] [Abstract][Full Text] [Related]
6. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Richter K; Janicki S; Jörres RA; Magnussen H
Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
[TBL] [Abstract][Full Text] [Related]
7. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm.
García R; Guerra P; Feo F; Galindo PA; Gómez E; Borja J; Fernandez-Pacheco R
J Investig Allergol Clin Immunol; 2001; 11(3):176-82. PubMed ID: 11831450
[TBL] [Abstract][Full Text] [Related]
8. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
[TBL] [Abstract][Full Text] [Related]
9. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
Chuchalin AG; Manjra AI; Rozinova NN; Skopková O; Cioppa GD; Till D; Kaiser G; Fashola T; Kottakis J
J Aerosol Med; 2005; 18(1):63-73. PubMed ID: 15741775
[TBL] [Abstract][Full Text] [Related]
10. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
11. Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children.
Pearlman D; Milgrom H; Till D; Ziehmer B
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):382-8. PubMed ID: 17042146
[TBL] [Abstract][Full Text] [Related]
12. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
13. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
[TBL] [Abstract][Full Text] [Related]
14. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children.
Henriksen JM; Agertoft L; Pedersen S
J Allergy Clin Immunol; 1992 Jun; 89(6):1176-82. PubMed ID: 1351489
[TBL] [Abstract][Full Text] [Related]
15. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer.
Nielsen KG; Skov M; Klug B; Ifversen M; Bisgaard H
Eur Respir J; 1997 Sep; 10(9):2105-9. PubMed ID: 9311511
[TBL] [Abstract][Full Text] [Related]
16. Formoterol via Turbuhaler gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents.
Grönneröd TA; von Berg A; Schwabe G; Soliman S
Respir Med; 2000 Jul; 94(7):661-7. PubMed ID: 10926337
[TBL] [Abstract][Full Text] [Related]
17. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma.
Bensch G; Berger WE; Blokhin BM; Socolovsky AL; Thomson MH; Till MD; Castellsague J; Della Cioppa G;
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575
[TBL] [Abstract][Full Text] [Related]
18. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children.
Daugbjerg P; Nielsen KG; Skov M; Bisgaard H
Acta Paediatr; 1996 Jun; 85(6):684-7. PubMed ID: 8816204
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
20. Protective effect and duration of action of formoterol aerosol on exercise-induced asthma.
Patessio A; Podda A; Carone M; Trombetta N; Donner CF
Eur Respir J; 1991 Mar; 4(3):296-300. PubMed ID: 1677894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
